Priscilla K. Brastianos

22.1k total citations · 2 hit papers
175 papers, 5.4k citations indexed

About

Priscilla K. Brastianos is a scholar working on Pulmonary and Respiratory Medicine, Genetics and Oncology. According to data from OpenAlex, Priscilla K. Brastianos has authored 175 papers receiving a total of 5.4k indexed citations (citations by other indexed papers that have themselves been cited), including 104 papers in Pulmonary and Respiratory Medicine, 70 papers in Genetics and 62 papers in Oncology. Recurrent topics in Priscilla K. Brastianos's work include Brain Metastases and Treatment (94 papers), Glioma Diagnosis and Treatment (69 papers) and Lung Cancer Research Studies (37 papers). Priscilla K. Brastianos is often cited by papers focused on Brain Metastases and Treatment (94 papers), Glioma Diagnosis and Treatment (69 papers) and Lung Cancer Research Studies (37 papers). Priscilla K. Brastianos collaborates with scholars based in United States, Germany and Canada. Priscilla K. Brastianos's co-authors include Sandro Santagata, Adrienne Boire, Daniel P. Cahill, Matthias Preusser, Manuel Valiente, Livia Garzia, Mia Bertalan, Nancy Wang, Christian Mawrin and William C. Hahn and has published in prestigious journals such as Nature Communications, Nature Genetics and Journal of Clinical Oncology.

In The Last Decade

Priscilla K. Brastianos

165 papers receiving 5.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations

2013 419 citations Priscilla K. Brastianos, Peleg Horowitz et al. profile →
Brain metastasis

2019 267 citations Adrienne Boire, Priscilla K. Brastianos et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Priscilla K. Brastianos United States	39	2.4k	1.9k	1.9k	1.3k	1.1k	175	5.4k
Eudocia Q. Lee United States	30	2.5k 1.1×	2.4k 1.2×	1.7k 0.9×	948 0.8×	742 0.7×	123	4.9k
Georg Widhalm Austria	40	2.0k 0.9×	2.7k 1.4×	1.6k 0.9×	879 0.7×	759 0.7×	213	5.7k
Jeffrey J. Raizer United States	43	2.0k 0.8×	3.3k 1.7×	1.5k 0.8×	968 0.8×	1.4k 1.2×	175	6.2k
Dieta Brandsma Netherlands	27	1.9k 0.8×	2.4k 1.2×	1.3k 0.7×	999 0.8×	505 0.4×	93	4.4k
Lakshmi Nayak United States	33	2.1k 0.9×	2.9k 1.5×	1.8k 1.0×	915 0.7×	618 0.5×	128	5.5k
Philippe Métellus France	38	1.8k 0.7×	2.2k 1.1×	993 0.5×	1.2k 0.9×	765 0.7×	170	5.3k
Frank Saran United Kingdom	34	1.8k 0.8×	3.7k 1.9×	852 0.5×	884 0.7×	1.2k 1.1×	149	6.2k
Émilie Le Rhun France	45	4.5k 1.9×	3.6k 1.8×	3.4k 1.8×	1.3k 1.0×	1.1k 0.9×	237	7.8k
Lawrence Kleinberg United States	41	2.8k 1.2×	2.3k 1.2×	1.5k 0.8×	938 0.7×	543 0.5×	230	5.5k
Jan Drappatz United States	42	1.2k 0.5×	3.0k 1.6×	1.1k 0.6×	934 0.7×	1.6k 1.4×	155	5.3k

Countries citing papers authored by Priscilla K. Brastianos

Since Specialization

Citations

This map shows the geographic impact of Priscilla K. Brastianos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Priscilla K. Brastianos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Priscilla K. Brastianos more than expected).

Fields of papers citing papers by Priscilla K. Brastianos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Priscilla K. Brastianos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Priscilla K. Brastianos. The network helps show where Priscilla K. Brastianos may publish in the future.

Co-authorship network of co-authors of Priscilla K. Brastianos

This figure shows the co-authorship network connecting the top 25 collaborators of Priscilla K. Brastianos. A scholar is included among the top collaborators of Priscilla K. Brastianos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Priscilla K. Brastianos. Priscilla K. Brastianos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cahill, Daniel P., et al.. (2025). Collision tumor, a metastatic melanoma within a meningioma: a case report. Acta Neuropathologica Communications. 13(1). 57–57.

Gathirua‐Mwangi, Wambui G., Holly Martin, Dan He, et al.. (2024). Real-world outcomes in patients with brain metastases secondary to HR+/HER2− MBC treated with abemaciclib and local intracranial therapy. The Oncologist. 30(8). 1 indexed citations

Duffau, Hugues, Mitchel S. Berger, Priscilla K. Brastianos, et al.. (2024). Introduction: Contemporary management of low-grade gliomas: from tumor biology to the patient’s quality of life. Neurosurgical FOCUS. 56(2). E1–E1. 1 indexed citations

Mair, Maximilian J., Rupert Bartsch, Émilie Le Rhun, et al.. (2023). Understanding the activity of antibody–drug conjugates in primary and secondary brain tumours. Nature Reviews Clinical Oncology. 20(6). 372–389. 45 indexed citations

Sabari, Joshua K., Vamsidhar Velcheti, K. Shimizu, et al.. (2022). Activity of Adagrasib (MRTX849) in Brain Metastases: Preclinical Models and Clinical Data from Patients with KRASG12C-Mutant Non–Small Cell Lung Cancer. Clinical Cancer Research. 28(15). 3318–3328. 78 indexed citations

Schiff, David, Hans Messersmith, Priscilla K. Brastianos, et al.. (2022). Radiation Therapy for Brain Metastases: ASCO Guideline Endorsement of ASTRO Guideline. Journal of Clinical Oncology. 40(20). 2271–2276. 47 indexed citations

Hulsbergen, Alexander, An Claes, Vasileios K. Kavouridis, et al.. (2020). Subtype switching in breast cancer brain metastases: a multicenter analysis. Neuro-Oncology. 22(8). 1173–1181. 75 indexed citations

Kaufmann, Timothy J., Marion Smits, Jerrold L. Boxerman, et al.. (2020). Consensus recommendations for a standardized brain tumor imaging protocol for clinical trials in brain metastases. Neuro-Oncology. 22(6). 757–772. 150 indexed citations

Cao, Yi, Jochen K. Lennerz, Ryan P. Frazier, et al.. (2019). Clinical Validation of a Cell-Free DNA Gene Panel. Journal of Molecular Diagnostics. 21(4). 632–645. 12 indexed citations

10.

Ippen, Franziska M., Christopher Alvarez‐Breckenridge, Benjamin M. Kuter, et al.. (2019). The Dual PI3K/mTOR Pathway Inhibitor GDC-0084 Achieves Antitumor Activity in PIK3CA -Mutant Breast Cancer Brain Metastases. Clinical Cancer Research. 25(11). 3374–3383. 61 indexed citations

11.

Juratli, Tareq A., Pamela S. Jones, Nancy Wang, et al.. (2019). Targeted treatment of papillary craniopharyngiomas harboring BRAF V600E mutations. Cancer. 125(17). 2910–2914. 66 indexed citations

12.

Boire, Adrienne, Dieta Brandsma, Priscilla K. Brastianos, et al.. (2019). Liquid biopsy in central nervous system metastases: a RANO review and proposals for clinical applications. Neuro-Oncology. 21(5). 571–584. 107 indexed citations

13.

Zhai, Lijie, Erik Ladomersky, Kristen L. Lauing, et al.. (2017). Infiltrating T Cells Increase IDO1 Expression in Glioblastoma and Contribute to Decreased Patient Survival. Clinical Cancer Research. 23(21). 6650–6660. 144 indexed citations

14.

Lyle, L. Tiffany, Paul R. Lockman, Chris E. Adkins, et al.. (2016). Alterations in Pericyte Subpopulations Are Associated with Elevated Blood–Tumor Barrier Permeability in Experimental Brain Metastasis of Breast Cancer. Clinical Cancer Research. 22(21). 5287–5299. 120 indexed citations

15.

Bi, Wenya Linda, Peleg Horowitz, Noah F. Greenwald, et al.. (2016). Landscape of Genomic Alterations in Pituitary Adenomas. Clinical Cancer Research. 23(7). 1841–1851. 88 indexed citations

16.

Sadelain, Michel, David Avigan, Priscilla K. Brastianos, et al.. (2015). Collaboration in Cancer Trials (October 26–27, 2015). The Oncologist. 20(S2). S1–S8. 2 indexed citations

17.

Gainor, Justin F., S. Andrew, Jennifer Logan, et al.. (2015). Alectinib Dose Escalation Reinduces Central Nervous System Responses in Patients with Anaplastic Lymphoma Kinase–Positive Non–Small Cell Lung Cancer Relapsing on Standard Dose Alectinib. Journal of Thoracic Oncology. 11(2). 256–260. 57 indexed citations

18.

Brastianos, Priscilla K. & Daniel P. Cahill. (2015). Management of brain metastases in the era of targeted and immunomodulatory therapies.. PubMed. 29(4). 261–3. 4 indexed citations

19.

Du, Ziming, Malak Abedalthagafi, Ayal A. Aizer, et al.. (2014). Increased expression of the immune modulatory molecule PD-L1 (CD274) in anaplastic meningioma. Oncotarget. 6(7). 4704–4716. 126 indexed citations

20.

Brastianos, Priscilla K. & Tracy T. Batchelor. (2010). Vascular endothelial growth factor inhibitors in malignant gliomas. Targeted Oncology. 5(3). 167–174. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact